Most Recent
Lead applicant in horse vaccine class action told to ‘put up or shut up’
Global animal health company Zoetis has told the lead applicants in a class action over horse vaccines to "put up or shut up" and produce evidence disclosing an alleged scientific link between the hendra virus vaccine and certain alleged adverse side effects.
Qantas worker caught watching porn on company iPad not unfairly dismissed, FWC says
A Qantas engineer who used his company-issued iPad to access pornographic material while at work has lost his unfair dismissal case.
Breast implants class action targets ‘incompetent’ surgeons
The lead applicants in a class action against The Cosmetic Institute have added 11 cosmetic surgeons to the lawsuit, alleging they conducted breast augmentation surgery in an "incompetent" manner.
Judge appoints referee to look at Halifax liquidators’ fees
A referee has been appointed to examine the fees for the liquidators of stockbroker Halifax Investment Services, which collapsed in December 2018, trapping around $200 million in client funds.
Lander & Rogers can’t escape review of $2M legal bill
National law firm Lander & Rogers has failed in its bid to stop a client reviewing invoices totalling $2 million, even though the legal fees were paid by a litigation funder.
‘Seriously dishonest conduct’: Former Liberal leader John Hewson sues Nine for defamation
Former Liberal leader John Hewson has filed a defamation suit against Nine, claiming a report by A Current Affair about his insurance firm was gratuitous and "seriously dishonest".
Maddens slammed for fee disclosures in bushfire class action
Maddens has once again been criticised for its non-compliant costs agreements, three months after receiving similar feedback from a Victoria Supreme Court judge overseeing the firm's bushfire class actions.
Mylan loses Lipidil appeal, despite court finding proof of intention not needed for Swiss-style claims
Mylan Health has lost its challenge to a ruling that invalidated three patents related to its blockbuster cholesterol drug Lipidil, despite the appeals court finding the primary judge had erred by ruling that proof of intention was required for Swiss-style claims.
More law firms pulled into Quintis class action as $46M insurance dispute heats up
Three law firms will represent the insurers in new proceedings launched to resolve a $46 million insurance question delaying settlement of two shareholder class actions against sandlewood producer Quintis, bringing the total number of law firms working on the class action to eight.
‘Disruptive and unsatisfactory’: Hytera slammed for late stage bid to adjourn copyright trial
Motorola has slammed Chinese radio manufacturer Hytera's "disruptive and unsatisfactory" request to adjourn a highly anticipated copyright trial over the alleged theft of source code which is due to begin in three weeks.